Roisin M P, Isambert M F, Henry J P, Guillot M, Lenoir G
Biochem Pharmacol. 1984 Jul 15;33(14):2245-52. doi: 10.1016/0006-2952(84)90662-2.
The catecholamine storage vesicles of a pheochromocytoma taken from a child have been isolated and characterized. The tumor contained almost exclusively noradrenaline and a large proportion of this amine was vesicle-bound. The noradrenaline-containing vesicles showed great resemblance to bovine chromaffin granules. Their catecholamine and dopamine beta-hydroxylase contents were that of chromaffin granules; their morphology and density were similar to those of the subpopulation of these granules that contain noradrenaline. The pheochromocytoma vesicles contained in their membranes an abundant polypeptide of mol. wt 110,000, which was not apparent in bovine adrenal medulla vesicle membranes. Monoamine uptake by pheochromocytoma noradrenaline vesicles did not differ significantly from that observed in bovine chromaffin granules. The time-course, plateau level and KM for noradrenaline were similar for both types of organelles. Both had an oligomycin-resistant ATPase with similar properties. Investigations using the tetrabenazine derivative [2-3H]dihydrotetrabenazine (2-hydroxy-3-isobutyl-9,10-dimethoxy-1,2,3,4,6, 7-hexahydro-11b-H-benzo[a]quinolizine), which binds specially to the bovine chromaffin granule monoamine carrier indicated that granule membranes from the tumor have a 10-fold increased number of [2-3H]dihydrotetrabenazine binding sites, with no change in dissociation constant. As in the case of bovine chromaffin granules, [2-3H]dihydrotetrabenazine can be totally displaced by noradrenaline and serotonin. To account for the discrepancy observed between the uptake data (which indicated no difference with bovine chromaffin granules) and the [2-3H]dihydrotetrabenazine binding studies (which showed a large excess of binding sites in the tumor membranes), we propose that granules in the investigated tumor contained a large amount of inactive monoamine carrier.
从一名儿童身上获取的嗜铬细胞瘤的儿茶酚胺储存囊泡已被分离并进行了特性分析。该肿瘤几乎只含有去甲肾上腺素,且大部分这种胺与囊泡结合。含去甲肾上腺素的囊泡与牛嗜铬颗粒极为相似。它们的儿茶酚胺和多巴胺β-羟化酶含量与嗜铬颗粒相同;其形态和密度与这些颗粒中含去甲肾上腺素的亚群相似。嗜铬细胞瘤囊泡的膜中含有一种丰富的分子量为110,000的多肽,这在牛肾上腺髓质囊泡膜中并不明显。嗜铬细胞瘤去甲肾上腺素囊泡对单胺的摄取与在牛嗜铬颗粒中观察到的情况没有显著差异。两种细胞器摄取去甲肾上腺素的时间进程、平台水平和米氏常数相似。两者都有一种对寡霉素有抗性的ATP酶,其性质相似。使用与牛嗜铬颗粒单胺载体特异性结合的四苯嗪衍生物[2-³H]二氢四苯嗪(2-羟基-3-异丁基-9,10-二甲氧基-1,2,3,4,6,7-六氢-11b-H-苯并[a]喹嗪)进行的研究表明,肿瘤的颗粒膜上[2-³H]二氢四苯嗪结合位点的数量增加了10倍,解离常数没有变化。与牛嗜铬颗粒的情况一样,[2-³H]二氢四苯嗪可被去甲肾上腺素和血清素完全取代。为了解释摄取数据(表明与牛嗜铬颗粒没有差异)和[2-³H]二氢四苯嗪结合研究(表明肿瘤膜中有大量过量的结合位点)之间观察到的差异,我们提出,所研究肿瘤中的颗粒含有大量无活性的单胺载体。